Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD



Status:Recruiting
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:50 - 110
Updated:4/21/2016
Start Date:April 2016
End Date:April 2019
Contact:Avner Ingerman, MD
Email:aingerman@ohrpharmaceutical.com
Phone:2126828452

Use our guide to learn which trials are right for you!

OHR-1601: A Phase III Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Solution, 0.2% Twice Daily in Subjects With Neovascular Age-Related Macular Degeneration (AMD)

A Phase 3 Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Solution 0.2%
Twice Daily in Subjects with Neovascular Age-Related Macular Degeneration. Patients will
receive injections of ranibizumab. In addition, patients will receive either Squalamine
lactate 0.2% eye drops or Placebo eye drops. The study duration is 2 years

Phase 3 Study of the Efficacy and Safety of Squalamine Lactate Ophthalmic Solution 0.2%
Twice Daily in Subjects with Neovascular Age-Related Macular Degeneration Methodology: Phase
III, multicenter, randomized, double-masked, placebo-controlled study conducted in 2 periods
(Year 1 and Year 2).

Year 1 (Screening/Baseline to Week 52): Patients will be randomly assigned to one of 2
treatment groups in a 1:1 ratio:

- Squalamine lactate ophthalmic solution, 0.2% BID (Years 1 and 2) + ranibizumab every 4
weeks (Year 1) and PRN ranibizumab (as needed, Year 2)

- Placebo ophthalmic solution BID (Years 1 and 2) + monthly ranibizumab every 4 weeks
(Year 1) and PRN ranibizumab (Year 2), based on optical coherence tomography
(OCT)-guided re-treatment criteria

Inclusion Criteria:

- Age ≥ 50 years

- A diagnosis of choroid neovascularization (CNV) secondary to AMD with CNV comprising
at least 50% of the total lesion area on fluorescein angiography (FA)

- Central subfield thickness (spectral domain (SD)-OCT central 1 mm) of ≥ 300 μm

- Best-corrected visual acuity (BCVA) 20/40 to 20/320 (73- to 24-letter score on the
Early Treatment of Diabetic Retinopathy Study [ETDRS] chart)

Exclusion Criteria:

- Neovascularization secondary to any other condition than AMD in the study eye; Blood
occupying greater than 50% of the AMD lesion, or blood > 1.0 sq. mm underlying the
fovea

- Pigment epithelial detachment (PED) without associated subretinal fluid and/or cystic
retinal changes

- Clinical evidence of diabetic retinopathy or diabetic macular edema in the study eye

- Confounding ocular conditions in the study eye which will affect interpretation of
OCT, VA or assessment of macular appearance (e.g., cataract, epiretinal membrane,
retinal vascular occlusive disease)

- Fibrosis or atrophy, retinal epithelial tear in the center of the fovea in the study
eye or any condition preventing VA improvement

- Uncontrolled glaucoma in the study eye, or currently receiving topical glaucoma
medication in the study eye
We found this trial at
21
sites
?
mi
from
Toms River, NJ
Click here to add this to my saved trials
Altamonte Springs, Florida 32701
?
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
?
mi
from
Arcadia, CA
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Bloomfield, NJ
Click here to add this to my saved trials
?
mi
from
Bridgeport, CT
Click here to add this to my saved trials
?
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Charlotte, North Carolina 28207
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
?
mi
from
Florissant, MO
Click here to add this to my saved trials
?
mi
from
Ft. Myers, FL
Click here to add this to my saved trials
?
mi
from
Kingston, PA
Click here to add this to my saved trials
LawrenceVille, New Jersey 08648
?
mi
from
LawrenceVille, NJ
Click here to add this to my saved trials
?
mi
from
Leawood, KS
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
New Brunswick, New Jersey 08901
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
?
mi
from
New London, CT
Click here to add this to my saved trials
?
mi
from
Ramsey, NJ
Click here to add this to my saved trials
?
mi
from
Rapid City, SD
Click here to add this to my saved trials
?
mi
from
Sarasota, FL
Click here to add this to my saved trials
?
mi
from
Syracuse, NY
Click here to add this to my saved trials
?
mi
from
Tucson, AZ
Click here to add this to my saved trials